A61P 5/24
Drugs for disorders of the endocrine system: of the sex hormones
Official title: of the sex hormones
A61P5/24 (Drugs for disorders of the endocrine system: of the sex hormones) appears on 2,837 US grants and 4,059 published applications in this corpus.
Search patents in A61P- Granted patents
- 2,837
- Published applications
- 4,059
- Assignees
- 1,344
- Inventors
- 6,471
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 3 | 0 |
| 1992 | 7 | 0 |
| 1993 | 11 | 0 |
| 1994 | 15 | 0 |
| 1995 | 18 | 0 |
| 1996 | 33 | 0 |
| 1997 | 27 | 0 |
| 1998 | 60 | 0 |
| 1999 | 66 | 0 |
| 2000 | 77 | 0 |
| 2001 | 81 | 27 |
| 2002 | 84 | 116 |
| 2003 | 86 | 216 |
| 2004 | 91 | 260 |
| 2005 | 75 | 266 |
| 2006 | 102 | 205 |
| 2007 | 91 | 206 |
| 2008 | 115 | 255 |
| 2009 | 110 | 267 |
| 2010 | 165 | 263 |
| 2011 | 151 | 223 |
| 2012 | 150 | 212 |
| 2013 | 153 | 168 |
| 2014 | 154 | 191 |
| 2015 | 148 | 162 |
| 2016 | 119 | 172 |
| 2017 | 117 | 138 |
| 2018 | 95 | 121 |
| 2019 | 81 | 111 |
| 2020 | 96 | 97 |
| 2021 | 64 | 85 |
| 2022 | 45 | 72 |
| 2023 | 41 | 76 |
| 2024 | 38 | 60 |
| 2025 | 38 | 54 |
| 2026 | 25 | 36 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Method of using a needle assisted injection device having reduced trigger force18 Aug 2026US 12,708,710 B2Antares Pharma, Inc.
- ALA and salt formulation11 Aug 2026US 12,702,656 B2Molecular Product Management, LLC
- Non-surgical prevention of boar taint and aggressive behavior4 Aug 2026US 12,697,342 B2Insigna Inc.
- Fixed dose oral testosterone undecanoate compositions and use thereof28 Jul 2026US 12,691,057 B1
- Non-surgical prevention of unpleasant odor in meats and aggressive or sexual behavior in male ruminants28 Jul 2026US 12,691,126 B2Insigna Inc.
- Compositions and methods for the treatment of congenital adrenal hyperplasia8 Oct 2026US 2026/0306485 A1Crinetics Pharmaceuticals, Inc.
- Lymph directing prodrugs24 Sep 2026US 2026/0284004 A1Monash University
- Glucuronidase activator, pharmaceutical composition, edible composition, and oral composition10 Sep 2026US 2026/0263540 A1Kaneka Corporation
- Androgen receptor antagonists for the treatment of patients with biochemical recurrence of hormone sensitive prostate cancer3 Sep 2026US 2026/0256742 A1
- Liquid formulation comprising trilostane20 Aug 2026US 2026/0240770 A1Norbrook Laboratories Limited
Most cited
By later US patents
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions930US 6,248,363 B1Lipocine Inc. · 2001
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions684US 6,923,988 B2Lipocine Inc. · 2005
- Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents617US 6,294,192 B1Lipocine Inc. · 2001
- Solid carriers for improved delivery of hydrophobic active ingredients in pharmaceutical compositions616US 6,569,463 B2Lipocine Inc. · 2003
- Implantable biocompatable immunoisolatory vehicle for delivery of selected therapeutic products448US 6,083,523 ABrown University · 2000